Clinical Trials Logo

Advanced Renal Cell Cancer clinical trials

View clinical trials related to Advanced Renal Cell Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02429440 Active, not recruiting - Renal Cell Cancer Clinical Trials

Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides

UroRCC
Start date: May 2005
Phase: Phase 1/Phase 2
Study type: Interventional

Clinical Phase I/II study to investigate the feasibility and tolerability of synthetic adjuvant peptide immunisation in combination with immune adjuvants (granulocyte macrophage colony stimulating factor; Montanide ISA-51) in patients with advanced renal cell cancer (RCC).